ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,615.35
0.55%
US Tech 100
19,804.00
0.64%
Dow Jones
40,000.90
0.62%
Brent Oil
84.57
0.00%
Bitcoin
58,338.58
0.77%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Eterna Therapeutics Inc (ERNA) Quote

Eterna Therapeutics Inc

Eterna Therapeutics Inc (ERNA)

Is $ul-sh Bd A
2.05
0.11
(5.67%)
Closed July 13 4:00PM
Delayed by 15 minutes
2.05
0.00
(0.00%)
After Hours: 4:56PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
2.05
Bid
1.76
Ask
2.90
Volume
8,127
1.95 Day's Range 2.11
0.840101 52 Week Range 2.99
Market Cap
10.496M
Previous Close
1.94
Open
1.95
Last Trade
3
@
1.96
Last Trade Time
Financial Volume
$ 16,374
VWAP
2.0147
Average Volume (3m)
7,372
Shares Outstanding
5,410,331
Dividend Yield
-
PE Ratio
-0.51
Earnings Per Share (EPS)
-4.01
Revenue
68k
Net Profit
-21.68M

About Eterna Therapeutics Inc

Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indicati... Eterna Therapeutics Inc is a biopharmaceutical company. The company develops transformational new medicines using advanced cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs. Show more

Sector
Pharmaceutical Preparations
Industry
Television Broadcast Station
Website
eternatx.com
Headquarters
Wilmington, Delaware, USA
Founded
2022
Eterna Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERNA. The last closing price for Eterna Therapeutics was $1.94. Over the last year, Eterna Therapeutics shares have traded in a share price range of $ 0.840101 to $ 2.99.

Eterna Therapeutics currently has 5,410,331 shares outstanding. The market capitalization of Eterna Therapeutics is $10.50 million. Eterna Therapeutics has a price to earnings ratio (PE ratio) of -0.51.

ERNA Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14 2024
Edgar (US Regulatory)

Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs i

The presentation reports the development of a beta 2 microglobulin-knockout (B2M-KO) iMSC line with enhanced immunosuppressive activity and stealthing features that may further augment the...

May 10 2024
GlobeNewswire Inc.

Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board

CAMBRIDGE, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a preclinical-stage biopharmaceutical company, committed to realizing the...

May 08 2024
GlobeNewswire Inc.

Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on the Development of a mRNA-Engineered iPSC Line which Mimics Native B2M Expression, via Targeted Insertion of HLA-E at the B2M Locus

Eterna reports the development of an mRNA-engineered iPSC line developed using UltraSlice™ to express a B2M-HLA-E fusion transgene in lieu of the endogenous B2M gene product to mimic native B2M...

May 07 2024
GlobeNewswire Inc.

Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors

CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science company committed to realizing the potential of mRNA cell...

February 20 2024
GlobeNewswire Inc.

Form 3 - Initial statement of beneficial ownership of securities

February 16 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 16 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

January 31 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

January 24 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

January 23 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.210.81081081081.852.111.7261011.86968256CS
40.15.128205128211.952.111.650154001.85979579CS
12002.052.53381.580173721.9880119CS
260.3319.18604651161.722.571.327883301.9409488CS
52-0.49-19.29133858272.542.990.840101159931.75396634CS
156-2.15-51.19047619054.27.150.840101348433.73011487CS
260-2.15-51.19047619054.27.150.840101348433.73011487CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VEVVicinity Motor Corporation
$ 0.7131
(122.15%)
116.26M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
IVPInspire Veterinary Partners Inc
$ 10.52
(88.19%)
41.79M
TOYOTOYO Company Ltd
$ 2.699
(74.13%)
56.65M
NISNNiSun International Enterprise Development Group Company Ltd
$ 9.11
(51.33%)
7.4M
SISIShineco Inc
$ 0.8446
(-60.16%)
6.71M
MCACMonterey Capital Acquisition Corporation
$ 3.54
(-49.50%)
364.7k
MCACUMonterey Capital Acquisition Corporation
$ 7.64
(-28.40%)
2.61k
GENEGenetic Technologies Ltd
$ 0.80
(-27.93%)
780.46k
KZIAKazia Therapeutics Ltd
$ 0.8975
(-27.62%)
25.62M
QLGNQualigen Therapeutics Inc
$ 0.428851
(108.89%)
420.2M
MAXNMaxeon Solar Technologies Ltd
$ 0.237
(-1.54%)
286.13M
NVDANVIDIA Corporation
$ 129.24
(1.44%)
251.69M
AGRIAgriFORCE Growing Systems Ltd
$ 0.1001
(21.92%)
192.82M
LCIDLucid Group Inc
$ 4.25
(25.00%)
167.79M

Discussion

View Full Feed
Seminole Red Seminole Red 2 minutes ago
'QAnon Shaman' Wants His Horned Headgear And Spear Back

https://www.msn.com/en-us/news/politics/qanon-shaman-wants-his-horned-headgear-and-spear-back/ar-BB1pU0hO?ocid=msedgntphdr&cvid=137cdbe30c1c48d6a5a12b41965f38a4&ei=112
meshcan meshcan 4 minutes ago
Great find!
ELTP
sab63090 sab63090 7 minutes ago
kund

it's good for you to challenge that; I certainly don't know for certain, but this is definitely a war between the believers and non-believers....so I will see how the momentum goes at this inflection point where the largest investors have sway in the coming days leading up to Jul
AVXL
cowtown jay cowtown jay 10 minutes ago
I used the "confused face" emoji to recognize having seen your post, but not able to tell if you were serious.

Look, what I see is that management doesn't want to waste time and money on the class action suit. The dereliction of duty by the tort lawyer will become all to obvious once
HGENQ
LetGoodTimesRoll LetGoodTimesRoll 17 minutes ago
ENOUGH SAID... $$$$$$$

"InnovaQor, Inc. (OTC: INQR) update. InnovaQor in 2023 initiated and continues to develop Curallo, a next-generation communication platform for medical professionals that will offer subscription-based services. We believe the success of InnovaQor will benefit Re
INQR
louieforpar louieforpar 18 minutes ago
Vice President Trump was certainly on his game here:




https://www.google.com/url?q=https://meidasnews.com/news/trump-forgets-names-for-3-minutes-straight-in-viral-supercut&sa=U&sqi=2&ved=2ahUKEwiz9t7TzqGHAxVVlokEHQWeC5cQFnoECA8QAQ&usg=AOvVaw1DvmIz-sYAVj2EOgmB90
capgain capgain 19 minutes ago
Billy Strings - Heartbeat of America (Live at Ryman Auditorium, Nashville, TN 2/25/24)

https://www.youtube.com/watch?v=qWAN5K2ke4Y
Me2Greedy Me2Greedy 20 minutes ago
I’m seeing two Gaps that could potentially get filled. $.54 & $3.00
MAXN
Seminole Red Seminole Red 21 minutes ago
Well-known doughnut chain Krispy Kreme was founded in North Carolina on this day in history, July 13, 1937.

Company founder Vernon Rudolph "bought a secret yeast-raised doughnut recipe from a New Orleans French chef," said the website for Krispy Kreme.

Rudolph set up a
toncatmad toncatmad 22 minutes ago
Looks like those dissolutions are going to happen here shortly

Searched for: Corporate Name: BioAmber
3 results were found, 3 returned.
Results 1-3

1.
BIOAMBER CANADA INC.
Status: Active - Dissolution Pending (Non-compliance)
Corporati
sab63090 sab63090 26 minutes ago
George:

Excellent information and I thank you for this explanation and examples.

I would never had even thought about it without you pointing it out in detail.
AVXL
sunspotter sunspotter 28 minutes ago
More lies from the French Canadian mafiosi behind WDRP.
WDRP
Can'tSparTheGhost Can'tSparTheGhost 28 minutes ago
With Hollywood and it's films being cleaned up, I'd say The Eagle will make a nice Splash🌊🦅

And Clean things up, so to speak...

How Refreshing!!!

NCSWIC!!!

$PSRU🤩
PSRU
JMoneyHoops JMoneyHoops 28 minutes ago
Exactly him becoming custodian would be best for shareholders
BCAP
sunspotter sunspotter 32 minutes ago
“ You also are on the clock to explain to everyone why a dirty ***** boy could conger up "Self purported " to Perfectly describe you!”

I think that’s meant to be “conjure” but perhaps he thinks the object of his contumely is a bit of an ‘eel?
CaptainObvious CaptainObvious 34 minutes ago
07/13/24 - 1,232,214,821
07/11/24 - 1,231,614,821
07/10/24 - 1,230,455,122
06/29/24 - 1,229,682,280
06/19/24 - 1,229,013,505
06/13/24 - 1,226,621,118
06/11/24 - 1,226,070,527
06/06/24 - 1,224,429,027
06/05/24 - 1,216,304,027
06/03/24 - 1
NWBO
Polymer Paul Polymer Paul 34 minutes ago
Bullrun has finally arrived for the small caps.... Interest rate cuts looming while the USA is officially not in a recession is very bullish! If KCC is right and lebby delivers then double digits by August. Vein there will be pull backs along the way .. these will be to take stop losses out so don't
LWLG
Tyrus603 Tyrus603 34 minutes ago
Intriguing thought... makes sense. Perhaps there will be some sort of telltale significant volume spike soon.
SPOM
capgain capgain 36 minutes ago
Hello B2B, I agree!
sab63090 sab63090 37 minutes ago
Yes, Tom....some people get excited right at the exact moment we hit a resistance level such as now, so it is probably best to wait to see if there is enough buying power to bust that resistance! Many think these technical levels are not valid, but they have proven to be very reliable for those pay
AVXL
Number sleven Number sleven 37 minutes ago
Nuke, That is a legal definition. It explains the difference between a matter of law and a matter of fact. In order to understand the ruling from the appeals court, this is an important distinction. They ruled that the information on the label and the advertising materials were both matters of fact.
AMRN
JusticeWillWin JusticeWillWin 38 minutes ago
29,781 shares AFTER-HOURS

https://www.nasdaq.com/market-activity/stocks/coop/after-hours
COOP

Your Recent History

NASDAQ
ERNA
Eterna Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved